Identification of the immune checkpoint signature of multiple myeloma using mass cytometry‐based single‐cell analysis
Abstract Objectives New targets or strategies are needed to increase the success of immune checkpoint‐based immunotherapy for multiple myeloma (MM). However, immune checkpoint signals in MM microenvironment have not been fully elucidated. Here, we aimed to have a broad overview of the different immu...
Main Authors: | Jinheng Wang, Yongjiang Zheng, Chenggong Tu, Hui Zhang, Karin Vanderkerken, Eline Menu, Jinbao Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Clinical & Translational Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1002/cti2.1132 |
Similar Items
-
Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises
by: Omar Alkharabsheh, et al.
Published: (2021-12-01) -
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
by: Emma Verheye, et al.
Published: (2022-01-01) -
Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
by: MUZAFFER KEKLIK, et al.
Published: (2012-01-01) -
Mass Cytometry Discovers Two Discrete Subsets of CD39−Treg Which Discriminate MGUS From Multiple Myeloma
by: Felix Marsh-Wakefield, et al.
Published: (2019-08-01) -
FLOW CYTOMETRY IN THE DIAGNOSIS AND MONITORING OF MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA
by: I. V. Galtseva, et al.
Published: (2017-06-01)